199 related articles for article (PubMed ID: 32266586)
1. Significance of HPV16 Viral Load Testing in Anal Cancer.
Małusecka E; Chmielik E; Suwiński R; Giglok M; Lange D; Rutkowski T; Mazurek AM
Pathol Oncol Res; 2020 Oct; 26(4):2191-2199. PubMed ID: 32266586
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
[TBL] [Abstract][Full Text] [Related]
5. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.
Valmary-Degano S; Jacquin E; Prétet JL; Monnien F; Girardo B; Arbez-Gindre F; Joly M; Bosset JF; Kantelip B; Mougin C
Hum Pathol; 2013 Jun; 44(6):992-1002. PubMed ID: 23266444
[TBL] [Abstract][Full Text] [Related]
6. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.
Biesaga B; Mucha-Małecka A; Janecka-Widła A; Kołodziej-Rzepa M; Szostek S; Słonina D; Kowalczyk A; Halaszka K; Przewoźnik M
J Cancer Res Clin Oncol; 2018 Jan; 144(1):63-73. PubMed ID: 29043437
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
Alemany L; Saunier M; Alvarado-Cabrero I; Quirós B; Salmeron J; Shin HR; Pirog EC; Guimerà N; Hernandez-Suarez G; Felix A; Clavero O; Lloveras B; Kasamatsu E; Goodman MT; Hernandez BY; Laco J; Tinoco L; Geraets DT; Lynch CF; Mandys V; Poljak M; Jach R; Verge J; Clavel C; Ndiaye C; Klaustermeier J; Cubilla A; Castellsagué X; Bravo IG; Pawlita M; Quint WG; Muñoz N; Bosch FX; de Sanjosé S;
Int J Cancer; 2015 Jan; 136(1):98-107. PubMed ID: 24817381
[TBL] [Abstract][Full Text] [Related]
8. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.
Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC
J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082
[TBL] [Abstract][Full Text] [Related]
9. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM
PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758
[TBL] [Abstract][Full Text] [Related]
11. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.
Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami HO; Ylitalo N; Sparén P
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):150-8. PubMed ID: 23155137
[TBL] [Abstract][Full Text] [Related]
13. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.
Evans MF; Matthews A; Kandil D; Adamson CS; Trotman WE; Cooper K
Head Neck Pathol; 2011 Dec; 5(4):344-8. PubMed ID: 21786153
[TBL] [Abstract][Full Text] [Related]
15. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
17. p53 and p16
Mohanty SK; Mishra SK; Bhardwaj N; Sardana R; Jaiswal S; Pattnaik N; Pradhan D; Sharma S; Kaushal S; Baisakh MR; Das S; Pradhan MR; Satapathy K; Pattnaik A; Sharma SK; Khadenga CR; Das S; Rath D; Nanda B; Parwani AV
Clin Genitourin Cancer; 2021 Dec; 19(6):510-520. PubMed ID: 34348854
[TBL] [Abstract][Full Text] [Related]
18. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
Halec G; Holzinger D; Schmitt M; Flechtenmacher C; Dyckhoff G; Lloveras B; Höfler D; Bosch FX; Pawlita M
Br J Cancer; 2013 Jul; 109(1):172-83. PubMed ID: 23778529
[TBL] [Abstract][Full Text] [Related]
19. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH;
Br J Dermatol; 2007 Sep; 157(3):523-30. PubMed ID: 17573882
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
